MTIC
VRTX icon

Missouri Trust & Investment Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Missouri Trust & Investment Company’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20
Closed -$9.07K – 421
2025
Q4 		$9.07K Hold
20
– – ﹤0.01% 327
2025
Q3 		$7.83K Sell
20
-7
-26% -$2.92K ﹤0.01% 349
2025
Q2 		$12K Buy
27
+7
+35% +$3.23K ﹤0.01% 310
2025
Q1 		$9.7K Hold
20
– – ﹤0.01% 317
2024
Q4 		$8.05K Hold
20
– – ﹤0.01% 327
2024
Q3 		$9.3K Hold
20
– – ﹤0.01% 305
2024
Q2 		$9.37K Buy
+20
New +$8.68K ﹤0.01% 305

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Missouri Trust & Investment Company's VRTX Position: Q1 2026 in Review

Missouri Trust & Investment Company sold out of Vertex Pharmaceuticals (VRTX) in Q1 2026, closing a stake of 20 shares — an estimated $9.07K sold.

Missouri Trust & Investment Company first reported a position in VRTX in Q2 2024 and held it in 7 quarters. The position peaked at $12K in Q2 2025. 1,695 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Missouri Trust & Investment Company reported no remaining Vertex Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Missouri Trust & Investment Company sold 20 Vertex Pharmaceuticals shares in Q1 2026, an estimated $9.07K.
  • Missouri Trust & Investment Company first reported a position in Vertex Pharmaceuticals in Q2 2024 and held it in 7 quarters.
  • Missouri Trust & Investment Company's Vertex Pharmaceuticals position peaked at $12K in Q2 2025.
  • 1,695 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q1 2026, filed 14 May 2026.